Investor's Business Daily on MSN
IBD Rating Upgrades: Teva Pharmaceutical ADR Flashes Improved Price Strength
A Relative Strength Rating upgrade for Teva Pharmaceutical ADR shows improving technical performance. Will it continue?
Investor's Business Daily on MSN
IBD Rating Upgrades: Heico Flashes Improved Price Strength
Heico HEI saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an upgrade from 70 to 74. Please ...
Investing.com -- Spyre Therapeutics (NASDAQ:SYRE) stock rose 4% Friday after Deutsche Bank analyst David Hoang initiated coverage with a Buy rating and a $43 price target, suggesting significant ...
The largest independent brokerages reaped the benefits of rising asset values and consolidation last year. Those trends drove some small but notable changes among the 15 biggest firms in the channel, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results